Sahpra reports about 600 fake medicine complaints this year, and new compounding rules aren't due until early next year, which industry head Stavros Nicolaou calls too late.
Recap by typeshit. Full story at Mail & Guardian.
Bloomberg reports the Kennedy plan to widen peptide access comes with a side effect reporting rule for compounding pharmacies.
A Facebook user explains that compounded GLP-1 versions were allowed during the branded drug shortage and flags what that means for people still using them.
The Warrington Guardian reports charges against staff over the theft of weight-loss injections valued at around £20,000.
Asahi Shimbun reports the arrests tied to prescription-free sales of Mounjaro and similar weight loss drugs riding the diet craze.
Healio
Biykem Bozkurt told the Cardiometabolic Health Congress that semaglutide and tirzepatide improve weight, exercise capacity and quality of life in obese HFpEF patients.
Christian Djurhuus and Nicholas Alp join moderator Bob DiLuzio in an Xtalks session on keeping people engaged with obesity care over time.
Loading…